EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases

Carina A Dehner, Baptiste Ameline, Fernanda Amary, John M Gross, Ying Zou, Michael Michal, Zdenek Kinkor, Jorge Torres-Mora, Faizan Malik, Erica Y Kao, Robert W Ricciotti, Nasir Ud Din und 8 weitere

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Carina A Dehner und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Pathology and Laboratory Medicine, University of…. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Nuclear Receptor Coactivator 2, Soft Tissue Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spindle cell rhabdomyosarcomas (SCRMS), recognized by the 2020 World Health Organization Classification of Tumors of Soft Tissue and Bone as a distinct entity, comprise a family of malignant skeletal muscle tumors sharing spindle cell morphology. To date, members of this family include (1) MyoD1-mutated SCRMS/sclerosing rhabdomyosarcomas (RMS), (2) intraosseous SCRMS with FET::TFCP2 or MEIS1::NCOA2 fusions, and (3) infantile/congenital SCRMS harboring NCOA1/2 or VGLL3 rearrangements. A rare, emerging subtype of SCRMS has been reported to harbor recurrent ZFP64::NCOA3 fusions. We studied 14 cases of this rare SCRMS subtype. The tumors presented in 11 men and 3 women (median age, 39.5 years; range, 22-69 years) and involved the thigh (4), lower leg (2), gluteal soft tissues (2), abdominal wall (1), mediastinum (1), subperiosteal surface of third rib (1), glottis (1), prostate (1), and pelvis (1). Morphologically, 11 tumors showed uniform spindle cell morphology with a fascicular architecture, whereas the remaining 3 tumors demonstrated focal or predominant round cell morphology. Extensive chondro-osseous differentiation was seen in 2 cases. By immunohistochemistry, tumors were variably positive for both desmin and MyoD1 (6 tumors), desmin, MyoD1, and myogenin (1 tumor), desmin alone (3 tumors of which only 1 was also tested for MyoD1), or MyoD1 alone (3 tumors). Smooth muscle actin was noted in 6 of 10 tested cases, and 2 of 5 tested cases showed ALK expression. A ZFP64::NCOA3 fusion was detected in 8 tumors, and a ZFP64::NCOA2 fusion was detected in 6 tumors. Methylation studies showed all but 1 tested tumor to form a tight cluster, clearly separate from other RMS subtypes and non-RMS morphologic mimics. Clinical follow-up (10/14 cases; median, 35 months; range, 3-108 months) demonstrated local recurrence in 2 patients and distant metastases in 5 patients (median, 12 months; range, at presentation - 106 months). At the time of last follow-up, 5 patients were alive without evidence of disease, 3 patients were alive with disease, and 2 patients died of disease at 34 and 108 months. We conclude that SCRMS with ZFP64::NCOA2/3 fusions represents a distinct, clinically aggressive sarcoma characterized by fascicular and sometimes round cell morphology, occasional chondro-osseous differentiation, and variable skeletal muscle marker expression. Recognition of this emerging subtype of SCRMS may have prognostic and therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyosarcomaNuclear Receptor Coactivator 2Soft Tissue NeoplasmsBiomarkers, TumorTranscription FactorsOncogene Proteins, FusionHumansMaleFemaleMiddle AgedAdultAgedYoung AdultGene Fusion

Stichwörter der Autor:innen

ZFP64::NCOA2/3fusion-associated spindle cell rhabdomyosarcomaspindle cell rhabdomyosarcoma

Substanzen

Nuclear Receptor Coactivator 2NCOA2 protein, humanBiomarkers, TumorTranscription FactorsOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Carina.…
  • Bone Tumor Reference Center at the Institute of Medical Genetics and Pathology, University Hospital, University of Basel, Basel, Switzerland.
  • Histopathology Department, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Greater London, United Kingdom; Cancer Institute, University College London, London, United Kingdom.
  • Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.
  • Biopticka Laboratory, Ltd, Plzen, Czech Republic; Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic.
  • Biopticka Laboratory, Ltd, Plzen, Czech Republic.

Förderung

  • NCI NIH HHS

Zitieren

APA

Dehner, C. A., Ameline, B., Amary, F., Gross, J. M., Zou, Y., Michal, M., Kinkor, Z., Torres-Mora, J., Malik, F., Kao, E. Y., Ricciotti, R. W., Din, N. U., John, I., Dickson, B. C., Demicco, E. G., Agaimy, A., Linos, K., Hameed, M. R., Folpe, A. L., & Baumhoer, D. (2025). Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100906

Vancouver

Dehner CA, Ameline B, Amary F, Gross JM, Zou Y, Michal M, et al. Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100906

BibTeX
@article{Dehner2025,
  author = {Dehner, Carina A and Ameline, Baptiste and Amary, Fernanda and Gross, John M and Zou, Ying and Michal, Michael and Kinkor, Zdenek and Torres-Mora, Jorge and Malik, Faizan and Kao, Erica Y and Ricciotti, Robert W and Din, Nasir Ud and John, Ivy and Dickson, Brendan C and Demicco, Elizabeth G and Agaimy, Abbas and Linos, Konstantinos and Hameed, Meera R and Folpe, Andrew L and Baumhoer, Daniel},
  title = {Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100906}
}
Kostenlos starten →